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Abstract
Objectives To describe the current use of airway clearance techniques among people with cystic 
fibrosis (CF) in the UK, and the baseline characteristics for users of different airway clearance 
techniques.
Design Analysis of the UK CF Registry 2011 data.
Setting and participants All people with CF in the UK aged 11 years (n=6372).
Results Of the 6372 people on the UK CF registry in 2011, 89% used airway clearance techniques.
The most commonly used primary techniques were forced expiratory techniques (28%) and
oscillating positive expiratory pressure (PEP) (23%). Postural drainage and high-frequency chest 
wall oscillation were used by 4% and 1% of people with CF, respectively. The male:female ratio of 
individuals who used exercise as their primary airway clearance technique was 2:1, compared with
1:1 for other techniques. Individuals with more severe lung disease tended to use devices such as
non-invasive ventilation or high-frequency chest wall oscillation.
Conclusions Forced expiratory techniques and oscillating PEP are the most common airway 
clearance techniques used by people with CF in the UK, and postural drainage and high-frequency 
chest wall oscillation are the least common techniques. This is significant in terms of planning 
airway clearance technique trials, where postural drainage has been used traditionally as the 
comparator. The use of airway clearance techniques varies between countries, but the reasons for 
these differences are unknown.
Keywords: Cystic fibrosis; Physiotherapy; Registries; Epidemiology 
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Introduction
Lung disease in people with cystic fibrosis (CF) is caused by retained airway secretions, 
inflammation and infection [1]. Chest physiotherapy to remove airway secretions is recommended 
by various CF organisations as a vital treatment for people with CF [2,3].
Many different airway clearance techniques have been developed and modified to optimise 
outcomes in CF [4]. Despite various studies and meta-analyses (including five Cochrane systematic 
reviews), the best airway clearance technique for people with CF has yet to be identified [5]. As 
such, it is recommended that airway clearance techniques should be tailored according to individual 
needs, lifestyle and symptoms [2,3]. Most people with CF have their own preferences for a 
particular airway clearance technique, as shown by the drop-outs in a recent randomised controlled 
trial of long-term airway clearance techniques [6].
As such, the airway clearance techniques used by people with CF vary between individuals 
attending the same CF centre, between CF centres in the same country, and between countries. An 
understanding of this variation would be useful in terms of planning future airway clearance 
technique trials, but the airway clearance techniques used in the UK have not been explored
systematically. This paper aims to describe the airway clearance techniques used by adolescents and 
adults with CF in the UK, to explore the baseline characteristics of people with CF using different 
airway clearance techniques, and to investigate usage patterns of airway clearance techniques by 
severity of lung disease.
<A>Methods
A cross-sectional analysis of all available data from the UK CF registry was undertaken for patients 
aged \HDUVLQ. The study had no exclusion criteria. Only data from people with CF aged 
11 years were included because airway clearance techniques suitable for younger children differ 
from those used by adolescents and adults [2]. Also, the inclusion of data from younger children 
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would move the focus towards techniques that are chosen as much for the needs of parents and 
families, who are more involved at that stage, as the needs of the person with CF.
<B>Data
The following data were obtained from the registry:
x demographics – age, sex;
x spirometry – forced expiratory volume in 1 second (FEV1) (in % predicted);
x annual total intravenous (IV) antibiotic-days (in number of days);
x use of mucolytic/osmotic – Dornase Alpha (DNase), nebulised hypertonic sodium chloride; and
x primary airway clearance – recorded within the UK CF registry as postural drainage, forced 
expiratory techniques (e.g. active cycle of breathing techniques), positive expiratory pressure (PEP),
oscillating PEP (e.g. Flutter valve and Acapella), high-frequency chest wall oscillation (e.g. vest),
other (usually non-invasive ventilation), exercise and none specified.
Data were collected during the annual review of people with CF between January and 
December 2011. Of note, the CF Trust made minor modifications to the airway clearance technique
categories in 2013, and the ‘forced expiratory techniques’ category was removed as forced 
expiratory techniques are now recognised to be an integral part of all airway clearance techniques in 
the UK. This removal was made following consultation with specialist physiotherapists working 
within CF care who were concerned that this ‘catch all’ heading did not allow differentiation 
between very different airway clearance techniques, such as autogenic drainage and active cycle of 
breathing techniques.
Analyses were restricted to primary airway clearance techniques due to missing data for 
secondary airway clearance techniques (no data were available for 51% of people with CF).
<B>Statistical analysis
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Excel 2010 (Microsoft Corp., Redmond, WA, USA) spreadsheets received from the UK CF 
Registry were converted into SPSS Version 20 (IBM Corp., Armonk, NY, USA) spreadsheets for 
data cleaning and analysis. 
The distribution of primary airway clearance techniques was described. Descriptive analysis 
of baseline characteristics (demographics, spirometry, annual total IV antibiotic-days, use of 
mucolytic/osmotic) was obtained for each airway clearance technique.
Severity of lung disease was divided into severe (% predicted FEV1 , moderate (% 
predicted FEV1 >40% to <70%) and mild (% predicted FEV1 . These divisions are used as 
the standard for epidemiological studies in CF [7], and are used by US and Canadian CF registries
[8,9]. The robustness of these divisions for this dataset was tested by comparing the total IV 
antibiotic-days for each group using the Kruskal-Wallis test. Annual total IV antibiotic-days 
increased with the severity of lung disease (Kruskal-Wallis P<0.0001), suggesting that the 
internationally adopted divisions were applicable to this dataset.
<insert Figure 1 near here>
Chi-squared test was used to test associations between airway clearance techniques, use of 
mucolytic/osmotic and severity of lung disease. All statistical tests were two-sided, and P<0.05 was
considered to indicate significance.
<A>Results
In total, 6372 people with CF aged \HDUVZHUH registered on the UK CF registry database in 
2011. There were no missing data for age and sex, and minimal missing data (<5%) for FEV1 and 
annual total IV antibiotic-days, as shown in Table 1. Missing data for use of DNase and nebulised 
hypertonic sodium chloride were difficult to ascertain as the data were collected by the UK CF 
Registry with a check-box, with no option for ‘not using’. Therefore, if the check-box was not 
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selected (i.e. ‘no data’), it could be that the respondent was not using that mucolytic/osmotic or it 
could represent missing data.
<insert Table 1 near here>
Fig. 2 shows that 89% of people with CF used airway clearance techniques in 2011. Forced 
expiratory techniques (including huff, active cycle of breathing techniques and autogenic drainage),
used by 28% of people with CF, were the most common, followed by oscillating PEP (23%). Only 
1% of people with CF in the UK used high-frequency chest wall oscillation as their primary airway 
clearance technique. Approximately 10% of people with CF did not use any airway clearance 
techniques.
<insert Fig. 2 near here>
Table A (see online supplementary material) shows the demographic data by airway 
clearance technique. People with CF who used exercise and those who did not use any airway 
clearance techniques appeared to have the mildest lung disease based on % predicted FEV1 (median 
78% and 78%, respectively) and annual IV antibiotic-days (median 3 days and 0 days,
respectively). People with CF using high-frequency chest wall oscillation or ‘other’ techniques 
(usually non-invasive ventilation) appeared to have the most severe lung disease, with median % 
predicted FEV1 of 63% and 65%, respectively. These two groups also had the highest annual IV 
antibiotic-days (median 26 days and 24 days, respectively). Further information about the 
distribution of continuous variables (age, FEV1 and total IV antibiotic-days) is available in Fig. A 
(see online supplementary material).
People with severe lung disease were more likely to use high-frequency chest wall 
oscillation [relative risk (RR) 2.75, 95% confidence interval (CI) 1.39 to 5.41] and forced 
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expiratory techniques (RR 1.79, 95% CI 1.61 to 1.99) than people with mild lung disease. People
with mild lung disease were more likely not to use any airway clearance techniques (RR 1.40, 95% 
CI 1.09 to 1.80), or to use exercise (RR 1.98, 95% CI 1.59 to 2.48) or PEP (RR 1.79, 95% CI 1.45
to 2.23) as their primary airway clearance technique compared with people with severe lung 
disease. The use of postural drainage and oscillating PEP was similar across severity categories. 
Table 2 shows the proportion of airway clearance techniques by severity of lung disease (Chi-
square, P<0.001).
<insert Table 2 near here>
Table 3 shows the use of mucolytic/osmotic by severity of lung disease. People with severe 
lung disease were more likely to use DNase than people with mild lung disease (RR 1.65, 95% CI 
1.55 to 1.75; overall Chi-square, p<0.0001). People with severe lung disease were more likely to 
use nebulised hypertonic sodium chloride than people with mild lung disease (RR 1.88, 95% CI 
1.63 to 2.17; overall Chi-square, p<0.0001).
<insert Table 3 near here>
As shown in Table A (see online supplementary material), people with CF who did not use
any airway clearance techniques were least likely to use DNase (29%, compared with the overall 
figure of 53%) and nebulised hypertonic sodium chloride (11%, compared with the overall figure of 
19%). On the other hand, people with CF who used high-frequency chest wall oscillation or ‘other’
techniques (usually non-invasive ventilation) were most likely to use DNase (67% and 67%,
respectively) and nebulised hypertonic sodium chloride (29% and 30%, respectively).
<A>Discussion
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<B>Levels of airway clearance technique use in the UK
Instead of ‘traditional’ techniques such as postural drainage (used by 4% of people with CF), more 
people with CF used techniques that can be self-administered:  forced expiratory techniques (28%),
oscillating PEP (23%) and PEP (16%). This is not surprising given that the ‘traditional’ techniques 
are relatively cumbersome and time-consuming to perform [10]. Postural drainage has gone out of 
favour due to the time required to facilitate mucociliary clearance [11]. There are also concerns that 
the head-down tilt may exacerbate gastro-oesophageal reflux and dyspnoea [12].
Three of the four recent randomised controlled trials on airway clearance techniques used
PEP or oscillating PEP in one of the comparator arms [13–15]. Given their level of use across 
different countries and the relative evidence of benefit, all future randomised control trials on 
airway clearance techniques should consider using PEP or oscillating PEP as a comparator.
<B>Variation by country
There is considerable between-county variation in airway clearance techniques (Table 4). For 
example, more than 50% of people with CF at the Buenos Aires CF centre in Argentina used
postural drainage as their main airway clearance technique [16], compared with 4% in the UK. 
High-frequency chest wall oscillation is used by 37% of people with CF in the USA [17], but only 
3% in Canada [18] and 1% in the UK. Exercise is the most common airway clearance technique in 
New Zealand (46% of adults) [19], compared with 16% in the UK. There is a strong preference for 
autogenic drainage in Ireland (46% of adults) [20], with other countries reporting autogenic 
drainage grouped with other breathing techniques (e.g. active cycle of breathing techniques) and 
figures ranging from 5% [18] to 33% [16].
Review of registry data for other countries revealed that airway clearance data for Australia, 
Brazil, France, Germany or the Netherlands were not included in the annual registry reports [21–
25]. Airway clearance data were also omitted from the European Cystic Fibrosis Society registry 
report [26]. However, 2010 data were available for Belgium, and showed that 90% of people with 
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CF on the registry underwent regular chest physiotherapy; no data were available regarding the
actual technique used [27].
<insert Table 4 near here>
In 2007, the Canadian Cystic Fibrosis Foundation created an Airway Clearance Working 
Group to collect airway clearance technique data from their CF clinics [18]. The results of this 
survey influenced the choice of airway clearance techniques used for the comparator and 
intervention arms in a recent multicentre randomised control trial [13]. The proportions of the 
different airway clearance techniques recorded for people with CF in the UK are broadly 
comparable with Canada, except for a bias towards PEP over oscillating PEP in Canada. This 
difference may be explained by several Canadian studies which found that PEP therapy is more 
effective than flutter devices (a form of oscillating PEP) [28] and postural drainage [29].
Interestingly, data from the 2011 Canadian registry report differed from this study: 34% of people 
with CF used PEP, 29% used percussion, 9% used other techniques, 8% used no airway clearance, 
7% used autogenic drainage or ‘breathing xercises’, 7% used high-frequency chest wall oscillation
and 6% used flutter devices [30]. The differences in the Canadian data over time may be due to the 
4-year gap between data collection, or issues such as data input and definitions.
<B>Limitations in using registry data
Limitations in using registry data to assess use of airway clearance techniques by people with CF
were demonstrated in the above descriptions of data from other countries. Many reports did not 
include any information about airway clearance, and some reports only included minimal data with 
no information about the technique used. Technique limitations were also displayed in this analysis 
of UK registry data because the airway clearance techniques available in 2011 were less well
defined, with no clear option for active cycle of breathing techniques or autogenic drainage. Instead,
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these different techniques were combined into a single category (forced expiratory techniques), 
which is likely to have affected the results of this registry analysis which found that forced 
expiratory techniques were the most common primary techniques for people with CF. This 
limitation has been addressed for UK registry data entered from 2013.
Other limitations are that CF registry data does not include information regarding 
adherence, opinions of people with CF, exact ‘prescription’ and health-related quality of life. This 
is evidenced by the low percentages of people with CF who reported that they did not use any
airway clearance techniques: 10% in this UK study, 4% in the New Zealand data, 8% in the 
Canadian registry data and no other reports within the other data identified in this paper [16–18,20]. 
Given that previous studies have often identified poor adherence to airway clearance, it seems 
unlikely that this is accurate.
Data input may also be an issue as the accuracy of the data is highly dependent on the clear 
labelling of categories within the registry, and the knowledge of the person inputting the data or 
providing the data to input. Non-physiotherapists may struggle to define what the patient is doing,
and which category this belongs to within a registry database.
It is likely that people with CF use more than one airway clearance technique. The authors
were unable to derive meaningful conclusions from the ‘secondary’ airway clearance technique data 
because no data were available for 51% of the people with CF, while less than 1% of the people 
with CF were not using any secondary airway clearance techniques. Nonetheless, it is expected that 
the registry data will be more robust following modifications made since 2013, and the 
implementation of a National Tariff for Cystic Fibrosis (payment by results) which will use registry 
data. 
The advantage of analysing the CF registry database is that a snapshot for all registered 
people with CF in the UK is available. As a result, this analysis has a larger sample size compared 
with previous analyses [16–18]. The UK CF registry database also has stringent quality control 
systems [31]. The small amount of missing data (<2% of data for ‘primary’ airway clearance 
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technique categories were missing) is testament to the high quality and comprehensive cover of the 
registry. The descriptive statistics provided in this paper are therefore representative of the main 
airway clearance techniques used by people with CF in the UK.
<B>Baseline characteristics
To the authors’ knowledge, this is the first paper is to describe the baseline characteristics of people 
with CF using various airway clearance techniques. People with mild lung disease were most likely 
to use exercise alone as their primary airway clearance technique, while people with severe lung 
disease were most likely to use high-frequency chest wall oscillation and nebulised 
mucolytics/osmotics. These results indicate a good degree of individualisation of airway clearance 
techniques by CF specialist physiotherapists, with some techniques (e.g. high-frequency chest wall 
oscillation, non-invasive ventilation) being reserved for sicker patients. However, recent trials 
comparing high-frequency chest wall oscillation with PEP have raised uncertainty regarding the 
effectiveness of high-frequency chest wall oscillation for airway clearance [13,32]. It will be 
interesting to repeat a similar analysis in several years’ time to determine if the pattern of airway 
clearance techniques changes with emerging evidence.
There was a 50%:50% split by sex for most airway clearance technique categories. 
However, the male:female ratio for people with CF using exercise as their primary airway clearance 
technique was almost 2:1. Given that the sex difference in habitual activities among people with CF
is well described [33], this result suggests that patient preference also exerts a significant influence 
on the choice of airway clearance technique. In addition, people with CF who do not use any 
primary airway clearance technique had high % predicted FEV1 (median 78%) and low total IV 
antibiotic-days (median 0), suggesting that these people may have felt well and therefore chose not 
to perform airway clearance. 
<B>Patient preference
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Patient preference is particularly pertinent in airway clearance because these are time-consuming, 
effortful and demanding activities to perform [6]. Adherence is crucial for an airway clearance 
technique to work optimally [4], and self-reported adherence correlates best with self-reported
satisfaction with a particular airway clearance technique [10]. There is emerging evidence that 
giving people with CF a choice of airway clearance techniques may improve outcome [34]. 
Nonetheless, patient preference alone does not guarantee efficacy – in the 2010 US multicentre 
randomised control trial on airway clearance techniques (whereby participants were randomised to 
different airway clearance techniques without taking their preferences into account), the attrition 
rate from the high-frequency chest wall oscillation arm was significantly lower compared with the 
oscillating PEP and postural drainage arms [15]. ‘Satisfaction with therapy’ was an independent 
predictor of drop-out [15]. However, the decrease in forced expiratory flow 25–75% (FEF25–75) in 
the high-frequency chest wall oscillation arm was significantly higher compared with the other two 
arms [15], suggesting a potential mismatch between objective and perceived efficacy [6].
This analysis found that approximately 15% of people with CF in the UK use exercise as 
their primary airway clearance technique. People with CF may perceive exercise to be a non-
stigmatising activity performed by all healthy people, so may choose to use exercise alone as an 
airway clearance technique despite recommendations to the contrary [2,3]. Evidence suggests that 
although exercise helps increase ease of sputum expectoration, it may not actually increase solid
content [35]. However, exercise has numerous other benefits and should be strongly encouraged as 
part of CF management and as an adjunctive therapy for airway clearance [36].
<B>Adherence
Other than the potential lack of efficacy of the preferred technique, another reason for the mismatch 
between personal preference and actual efficacy of the airway clearance techniques may simply be 
overestimation of adherence to certain airway clearance techniques. The lack of adherence data 
within registries is a limitation. However, issues have also been raised around how adherence could 
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be reported if registries were to collect this data. Electronic data capture (EDC) has demonstrated 
that self-report among people with CF is notoriously unreliable. For example, people with CF 
reported a median adherence of 80% to nebulised treatment, but objective median adherence was 
only 36% [37]. Airway clearance has historically been invisible, with only self-report or crude time 
loggers to guide visualisation of adherence. Making airway clearance and physical activity visible 
with EDC will be an important step towards more meaningful analysis of the results of future 
comparative trials of airway clearance techniques. Physical activity can be quantified objectively 
with an accelerometer [38], and the use of PEP and oscillating PEP may be measured with 
electronic chip card recording.
<A>Conclusion
This UK CF registry analysis found that many people with CF do not use any airway clearance 
techniques, or use exercise as their primary airway clearance technique despite the fact that this is
not recommended [2,3]. Forced expiratory techniques and airway clearance devices (PEP and 
oscillating PEP) were found to be the most common primary airway clearance techniques used by 
people with CF in the UK, while postural drainage and high-frequency chest wall oscillation are the 
least common techniques (used by 4% and 1%, respectively). This is a significant finding in terms 
of planning airway clearance technique trials where postural drainage has been used traditionally as 
the ‘gold standard’ comparator. Continuation of this practice would risk the recruitment of
sufficient participants to a trial, and calls into question the applicability of the results to a 
population that does not tend to use these techniques.
This work demonstrates variation in the use of different airway clearance techniques 
between countries. It does not explain whether these differences are influenced by technique 
accessibility, clinician cultural or knowledge differences, patient cultural or knowledge differences, 
overall differences in emphasis of different treatments or other factors. This poses an important 
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research question to identify the factors that cause variation in the use of different airway clearance 
techniques between countries.
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Fig. 1. Box-and-whisker plots of total intravenous (IV) antibiotic-days by severity of lung 
disease. FEV1, forced expiratory volume in 1 second. 
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Fig. 2. Airway clearance techniques (n=6372). PWCF, people with cystic fibrosis; PEP, 
peak expiratory pressure. 
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Table 1 
Demographic details for people with cystic fibrosis (CF) included in this analysis (n=6372) 
 
Age (years) 
Median (IQR) 
Missing data (%) 
23 (15) 
0 
 
Sex  
Male, n (%) 
Female, n (%) 
Missing data, n (%) 
3461 (54%) 
2911 (46%) 
0 
 
FEV1 (% predicted) 
Median (IQR) 
Missing data (%) 
71.9 (37.1) 
247 (4%) 
Total intravenous 
antibiotic-days 
 
Median (IQR) 
Missing data (%) 
 
14 (37) 
111 (2%) 
 
Use of DNase  
Yes, n (%) 
No dataa, n (%) 
3387 (53%) 
2985 (47%) 
Use of nebulised 
hypertonic sodium 
chloride  
Yes, n (%) 
No dataa, n (%) 
1205 (19%) 
5167 (81%) 
IQR, interquartile range; FEV1, forced expiratory volume in 1 second. 
aData for use of DNase and nebulised hypertonic sodium chloride were collected by the 
UK CF Registry with a check-ER[ZLWKQRRSWLRQIRUµnot using¶. Therefore, if the check-box 
was not selected (i.e. µno data¶), it could be a person with CF was not using that 
mucolytic/osmotic, but it could also represent missing data. 
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Table 2 
Proportion of people with cystic fibrosis using different airway clearance techniques 
 
 
Airway clearance 
techniques 
 
Severe lung disease  
(% FEV1  
n=811 
Moderate lung 
disease  
(% FEV1 >40% to 
<70%) 
n=2052 
 
Mild lung disease 
(% FEV1  
n=3181 
 
Postural drainage  
 
37 (5%) 
 
95 (5%) 
 
127 (4%) 
 
Forced expiratory 
techniques 
 
332 (41%) 
 
630 (33%) 
 
727 (23%) 
 
Oscillating PEP 
 
184 (23%) 
 
485 (23%) 
 
727 (23%) 
 
PEP 
 
84 (10%) 
 
288 (14%) 
 
592 (19%) 
 
High-frequency chest 
wall oscillation 
 
14 (2%) 
 
18 (1%) 
 
20 (1%) 
 
Other 
 
17 (2%) 
 
19 (1%) 
 
24 (1%) 
 
Exercise 
 
78 (10%) 
 
311 (15%) 
 
607 (19%) 
 
None 
 
65 (8%) 
 
166 (8%) 
 
357 (11%) 
PEP, positive expiratory pressure. 
Chi-square test P-value comparing airway clearance technique by severity of lung disease 
<0.0001. 
None of the cells had an expected count <5. The minimum expected count was 7.  
Missing data=328 (5%). 
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Table 3 
 Proportion of people with cystic fibrosis using nebulised mucolytic/osmotic to help with 
airway clearance 
 
 
Severe lung 
disease  
(% FEV1  
n=824 
Moderate lung 
disease  
(% FEV1 >40% 
to <70%) 
n=2074 
 
Mild lung 
disease 
(% FEV1  
n=3227 
DNase 
        No data 
        Yes 
 
244 (30%) 
580 (70%) 
 
769 (37%) 
1305 (63%) 
 
1848 (57%) 
1379 (43%) 
Nebulised hypertonic sodium 
chloride  
        No data 
        Yes 
 
 
607 (74%) 
217 (26%) 
 
 
1586 (76%) 
488 (24%) 
 
 
2776 (86%) 
451 (14%) 
FEV1, forced expiratory volume in 1 second. 
Chi-square test p-value comparing use of DNase by severity of lung disease <0.0001 
Chi-square test p-value comparing use of nebulised hypertonic sodium chloride by severity 
of lung disease <0.0001 
None of the cells had an expected count <5. For use of DNase, minimum expected count 
was 385. For use of nebulised hypertonic sodium chloride, minimum expected count was 
156. 
Missing data=247 (4%). 
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Table 4 
 Comparison of airway clearance technique use in the UK with other countries 
 UK data 
2011 
(n=6372) 
11 years 
New Zealand 
data 
2011 
(n=138) 
16 years 
Canada 
data 2011 
(n=3913) 
All ages 
Canada data 
2008 
(n=2363) 
All ages 
Ireland data 
(n=388) 
Adult data 
US data 
(n=204)a 
Adult data 
Argentina data 
(n=110)a 
Child data 
 
Postural drainage 
Forced expiratory techniques 
(including huff, ACBT and AD) 
 
Oscillating PEP 
PEP 
High frequency chest wall 
oscillation 
 
Exercise 
Percussion 
Other 
None 
 
4% 
 
28% 
 
23% 
16% 
 
1% 
 
16% 
 
1% 
10% 
 
2% 
 
14% 
 
17% 
23% 
 
2% 
 
46% 
 
0% 
4% 
 
N/A 
 
7% 
 
6% 
34% 
 
7% 
 
 
29% 
9% 
8% 
 
20% 
 
5% 
 
8% 
40% 
 
3% 
 
 
 
 
0% 
3% (ACBT) 
46% (AD) 
 
17% 
10% 
 
4% 
 
 
0% 
3% 
 
19% 
 
25% 
 
15% 
 
 
37% 
 
 
 
54% 
 
33% 
 
 
11%b 
 
 
 
 
 
Data source/collection method UK CF 
registry 
database 
2011 
New Zealand 
registry 
report 2011 
[19] 
Canadian 
registry 
report 
2011 [30] 
McIlwaine et al. 
2008 [18] using 
records from 24 
CF clinics 
CF registry of 
Ireland 2011 
[20] 
Sawicki et al. 2009 
[17] using 
questionnaire as part 
of project on Adult 
Care in CF study 
Ratto et al. 2012 [16] ± 
Records from a single 
CF clinic 
 
ACBT, active cycle of breathing techniques; AD, autogenic drainage; PEP, peak expiratory pressure; CF, cystic fibrosis. 
aMore than one airway clearance technique may be recorded if a person with cystic fibrosis used more than one technique. 
b11% PEP and oscillating PEP.  
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